121 related articles for article (PubMed ID: 6208197)
1. The measurement of the relative efficacy of agonists by selective potentiation of tissue responses: studies with isoprenaline and prenalterol in cardiac tissue.
Kenakin TP; Beek D
J Auton Pharmacol; 1984 Sep; 4(3):153-9. PubMed ID: 6208197
[TBL] [Abstract][Full Text] [Related]
2. Effects of in vivo treatment with isoprenaline or prenalterol on beta-adrenoceptor mechanisms in the heart and soleus muscle of the cat.
Hedberg A; Mattsson H; Nerme V; Carlsson E
Naunyn Schmiedebergs Arch Pharmacol; 1984 Mar; 325(3):251-8. PubMed ID: 6145101
[TBL] [Abstract][Full Text] [Related]
3. The lack of a pronounced preference of prenalterol for the beta-l-adrenoceptor subtype.
Rohm N; Wagner J; Schümann HJ
Naunyn Schmiedebergs Arch Pharmacol; 1980; 315(1):85-8. PubMed ID: 6113550
[TBL] [Abstract][Full Text] [Related]
4. Relative efficacy of prenalterol and pirbuterol for beta-1 adrenoceptors: measurement of agonist affinity by alteration of receptor number.
Kenakin TP; Beek D
J Pharmacol Exp Ther; 1984 May; 229(2):340-5. PubMed ID: 6143816
[TBL] [Abstract][Full Text] [Related]
5. Actions of prenalterol, a new cardioselective beta1-agonist, terbutaline and isoprenaline on electrophysiological and mechanical parameters of guinea pig atrial and papillary muscles.
Arlock P
Acta Pharmacol Toxicol (Copenh); 1982 Jul; 51(1):12-9. PubMed ID: 6126991
[TBL] [Abstract][Full Text] [Related]
6. Basic pharmacological properties of prenalterol.
Mattsson H; Hedberg A; Carlsson E
Acta Med Scand Suppl; 1982; 659():9-37. PubMed ID: 6127902
[No Abstract] [Full Text] [Related]
7. Intrinsic sympathomimetic activity of the partial agonist prenalterol in relation to beta adrenoceptor interaction in various tissues, in vitro.
Mattsson H; Hedberg A; Carlsson E
J Pharmacol Exp Ther; 1983 Mar; 224(3):654-61. PubMed ID: 6131123
[TBL] [Abstract][Full Text] [Related]
8. Characterization of mechanical effects and beta-adrenoceptor binding of prenalterol in rat myocardium.
Aass H; Hedberg A; Skomedal T; Carlsson E; Osnes JB
Acta Pharmacol Toxicol (Copenh); 1983 Jul; 53(1):3-11. PubMed ID: 6310958
[TBL] [Abstract][Full Text] [Related]
9. The influence of molecular structure on the affinity and efficacy of some beta-adrenoceptor agonists.
Molenaar P; McPherson GA; Malta E; Raper C
Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov; 331(2-3):240-6. PubMed ID: 2868416
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the properties of prenalterol and corwin at beta 1- and beta 2-adrenoreceptors in vitro.
Gurden JM; Apperley GH; Drew GM
J Auton Pharmacol; 1989 Apr; 9(2):79-91. PubMed ID: 2565903
[TBL] [Abstract][Full Text] [Related]
11. Is prenalterol (H133/80) really a selective beta 1 adrenoceptor agonist? Tissue selectivity resulting from differences in stimulus-response relationships.
Kenakin TP; Beek D
J Pharmacol Exp Ther; 1980 May; 213(2):406-13. PubMed ID: 6102602
[No Abstract] [Full Text] [Related]
12. Theoretical and practical problems with the assessment of intrinsic efficacy of agonists: efficacy of reputed beta-1 selective adrenoceptor agonists for beta-2 adrenoceptors.
Kenakin TP
J Pharmacol Exp Ther; 1982 Nov; 223(2):416-23. PubMed ID: 6127403
[TBL] [Abstract][Full Text] [Related]
13. Prenalterol is an agonist at beta 2- as well as at beta 1-adrenoceptors.
Apperley GH; Drew GM; Sullivan AT
Eur J Pharmacol; 1982 Jul; 81(4):659-63. PubMed ID: 6126381
[TBL] [Abstract][Full Text] [Related]
14. In vitro studies on the cardiac activity of prenalterol with reference to use in congestive heart failure.
Kenakin TP; Beek D
J Pharmacol Exp Ther; 1982 Jan; 220(1):77-85. PubMed ID: 6118432
[No Abstract] [Full Text] [Related]
15. Comparison of the effects of forskolin and isoprenaline on tracheal, cardiac and skeletal muscles from guinea-pig.
Waldeck B; Widmark E
Eur J Pharmacol; 1985 Jun; 112(3):349-53. PubMed ID: 4040470
[TBL] [Abstract][Full Text] [Related]
16. beta 1-and beta 2-adrenoceptor stimulatory effects of prenalterol.
Mattsson H; Andersson T; Carlsson E; Hedberg A; Lundgren B; Olsson T
Naunyn Schmiedebergs Arch Pharmacol; 1982 Dec; 321(4):302-8. PubMed ID: 6132344
[TBL] [Abstract][Full Text] [Related]
17. Role of cyclic AMP in cardiac beta-adrenoceptor desensitization: studies using prenalterol and inhibitors of phosphodiesterase.
Bobik A; Little PJ
J Cardiovasc Pharmacol; 1984; 6(5):795-801. PubMed ID: 6209482
[TBL] [Abstract][Full Text] [Related]
18. Cardiostimulatory effects of prenalterol, a beta-1 adrenoceptor partial agonist, in vivo and in vitro. Correlation between physiological effects and adenylate cyclase activity.
Hedberg A; Carlsson E; Fellenius E; Lundgren B
Naunyn Schmiedebergs Arch Pharmacol; 1982 Feb; 318(3):185-91. PubMed ID: 6121296
[TBL] [Abstract][Full Text] [Related]
19. Selectivity of prenalterol for adrenergic receptor subtypes: a potential mechanism of inotropic selectivity.
Williams RS
J Cardiovasc Pharmacol; 1983; 5(2):266-71. PubMed ID: 6188901
[TBL] [Abstract][Full Text] [Related]
20. beta 1-Adrenoceptors mediating relaxation of the guinea-pig trachea: experiments with prenalterol, a beta 1-selective adrenoceptor agonist.
Johansson U; Waldeck B
J Pharm Pharmacol; 1981 Jun; 33(6):353-6. PubMed ID: 6115005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
